Global Patient Monitoring Devices Market Poised for Remarkable Growth, Reaches USD 125.2 Million by 2032

Future Market Insights (FMI) has unveiled a comprehensive market study highlighting significant expansion in the global patient monitoring devices market. In 2022, the market achieved a robust valuation of USD 46.4 million. With a projected Compound Annual Growth Rate (CAGR) of 10.5% from 2022 to 2032, FMI anticipates the market will soar to an estimated USD 125.2 million by 2032.

The healthcare industry is increasingly embracing continuous monitoring and management of patient health, fueling a heightened demand for advanced patient monitoring devices. FMI’s report underscores the pivotal role of these devices in facilitating proactive healthcare management and enhancing patient outcomes through real-time data.

Secure Your Sample Report Offering The Most Recent Market Analysis

Among the various segments, Blood Glucose Monitoring Systems are anticipated to spearhead market growth, with an impressive forecasted CAGR of approximately 12.2% during the forecast period. This surge is driven by a growing emphasis on proactive health management and the critical need for precise, real-time monitoring to ensure optimal patient care.

The patient monitoring devices industry has undergone substantial growth and innovation in recent years, reshaping the landscape of healthcare by transforming the way providers track and manage patient health. These devices, which continuously monitor crucial physiological parameters such as heart rate, blood pressure, respiratory rate, and temperature, have become indispensable tools for healthcare professionals.

By providing real-time data and instant alerts, patient monitoring devices empower healthcare providers to detect any changes in a patient’s condition promptly. This proactive approach enables timely and appropriate interventions, ultimately improving patient outcomes.

The key factors driving the growth of the patient monitoring devices industry include advancements in technology, increased awareness of preventive healthcare, and the rising prevalence of chronic diseases. These factors contribute to a growing demand for innovative and efficient monitoring solutions, propelling the market forward.

As the industry continues to evolve, stakeholders, including manufacturers, healthcare providers, and investors, are keenly watching the developments and opportunities within this burgeoning market. Future Market Insights’ comprehensive report provides valuable insights for informed decision-making and strategic planning in this dynamic landscape.

The projected growth of the patient monitoring devices industry underscores its pivotal role in shaping the future of healthcare. As technology continues to advance, these devices will likely play an even more integral role in enhancing patient care and contributing to the overall efficiency of healthcare systems globally.

Key Takeaways: Patient Monitoring Devices Market

• The global patient monitoring devices market is experiencing significant growth, reaching a valuation of USD 46.4 million in 2022.
• The market is expected to expand at a CAGR of 10.5% from 2022 to 2032, reaching USD 125.2 million by 2032.
• The US holds the largest market share, projected to reach USD 48 billion by 2032 with a CAGR of 11.1%.
• The UK and Japan markets are also anticipated to grow substantially, reaching USD 5.5 million and USD 4.7 billion respectively by 2032.

Competitive Analysis:

• Honeywell,
• American Telecare,
• Roche,
• Philips Healthcare,
• Intel,
• Welch Allyn,
• Health anywhere Inc.,
• Johnson & Johnson,
• Bosch,
• Biotronik,
• Covidien Plc

Full Report Instantly – Drive Your Strategy Forward

Some of the recent developments of Patient Monitoring Devices Market key providers are as follows:

• In October 2021, Honeywell unveiled the Real-Time Health Monitoring System (RTHMS), integrating advanced hardware with data analytics software to enhance real-time and remote patient monitoring. This system also aims to digitize and automate critical and time-consuming tasks for medical staff, potentially reducing administrative workload by 35%.
• In June 2020, Abbott received FDA approval for the FreeStyle Libre 2 Integrated Continuous Glucose Monitoring (iCGM) device. This innovative device measures glucose levels every minute and features real-time alarms. Its self-applied iCGM sensor eliminates the need for finger pricks, with Bluetooth technology providing automatic alerts for any significant changes in blood glucose levels.
• In January 2020, Medtronic obtained FDA clearance for the Micra AV, recognized as the smallest pacemaker designed for atrioventricular synchronization.

Segments Covered in Patient monitoring devices industry Analysis:

By Product Type:

• Blood Glucose Monitoring Systems
  • Self-monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
• Cardiac Monitoring Devices
  • ECG Devices
  • Implantable Loop Recorders
  • Event Monitors
  • Mobile Cardiac Telemetry Monitors
  • Smart/Wearable ECG Monitors
• Multi-parameter Monitoring Devices
  • Low-acuity Monitoring Devices
  • Mid-acuity Monitoring Devices
  • High-acuity Monitoring Devices
  • Overall
  • Pulse Oximeters
  • Spirometers
  • Capnography
  • Peak Flow Meters
• Temperature Monitoring Devices
  • Handheld Temperature Monitoring Devices
  • Table-top Temperature Monitoring Devices
  • Wearable Continuous Monitoring Devices
  • Invasive Temperature Monitoring Devices
  • Smart Temperature Monitoring Devices

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Other End-user

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube